<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Recent works claiming that <z:e sem="disease" ids="C0409980" disease_type="Disease or Syndrome" abbrv="">primary antiphospholipid syndrome</z:e> (PAPS) cannot be clinically distinguished from multiple <z:mp ids='MP_0000612'>sclerosis</z:mp> (MS) recommend that MS patients be screened for anticardiolipin antibodies (ACA) </plain></SENT>
<SENT sid="1" pm="."><plain>In this study 296 randomly selected patients with MS and clinically isolated syndromes and 51 healthy controls were analyzed; ACA, anti-beta2-<z:chebi fb="2" ids="17089">glycoprotein</z:chebi> I, or antiprothrombin was found in 6 patients </plain></SENT>
<SENT sid="2" pm="."><plain>No predominance of any kind of clinical manifestations and no cardinal manifestations of PAPS were found in these patients </plain></SENT>
<SENT sid="3" pm="."><plain>ACA tests should be performed only when a suspicion of PAPS is raised and atypical clinical presentation for MS is found </plain></SENT>
</text></document>